Renaissance Technologies’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
Other funds holding CYAD
Renaissance Technologies's CYAD Position: Q3 2020 in Review
Renaissance Technologies sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q3 2020, closing a stake of 10,300 shares — an estimated $110K sold.
Renaissance Technologies first reported a position in CYAD in Q4 2017 and held it in 4 quarters. The position peaked at $230K in Q1 2018. 7 funds tracked by Wall St. Rank hold CYAD as of Q3 2020.
- Renaissance Technologies reported no remaining Celyad Oncology SA American Depositary Shares position as of Q3 2020 after selling out during the quarter.
- Renaissance Technologies sold 10,300 Celyad Oncology SA American Depositary Shares shares in Q3 2020, an estimated $110K.
- Renaissance Technologies first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2017 and held it in 4 quarters.
- Renaissance Technologies's Celyad Oncology SA American Depositary Shares position peaked at $230K in Q1 2018.
- 7 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q3 2020.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.